Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Aromateka Jeorjia | Beauty & Personal Care | 30.7% | 97th pct | 35 |
| Style | Beauty & Personal Care | 14.1% | 57th pct | 35 |
| Prema | Beauty & Personal Care | 7.3% | 31st pct | 35 |
| Eivon Kosmetiks Sakartv… | Beauty & Personal Care | 1.6% | 14th pct | 35 |
| Satsalo Momsakhureba | Beauty & Personal Care | -2.4% | 6th pct | 35 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Style | Eivon Kosmetiks Sakartv… | Aromateka Jeorjia | Prema | Satsalo Momsakhureba |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 44.5% | 49.2% | 55.6% | 14.3% | 53.7% |
| EBITDA Margin | 14.1% | 1.6% | 30.7% | 7.3% | -2.4% |
| EBITDAR | 2,950 | 323 | 4,216 | 901 | 1,779 |
| EBITDAR Margin | 14.1% | 1.6% | 39.8% | 8.7% | 20.3% |
| EBIT Margin | 8.8% | 1.2% | 29.4% | 6.0% | -4.8% |
| Net Profit Margin | 6.4% | 1.5% | 29.8% | 6.9% | -2.5% |
| Operating Expense % of Sales | 30.4% | 50.7% | 24.8% | 7.0% | 56.1% |
| Returns | |||||
| Return on Assets (ROA) | 10.1% | 4.2% | 29.1% | 8.8% | -3.8% |
| Return on Equity (ROE) | 121.7% | 8.1% | 38.3% | 9.1% | N/A |
| ROIC [EBIT / Invested Capital] | 18.9% | ||||
| 14.0% |
| 76.5% |
| 9.0% |
| -13.1% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 80.8% | 0.0% | 1.3% | 1.0% | 81.4% |
| Debt-to-Equity | 9.71x | 0.00x | 0.02x | 0.01x | -4.32x |
| Debt-to-EBITDA | 3.62x | 0.00x | 0.04x | 0.11x | N/A |
| Equity-to-Assets | 8.3% | 51.4% | 75.9% | 96.5% | -18.8% |
| Net Debt | 8,642 | -2,004 | -4,152 | -826 | 4,327 |
| Cash & Equivalents | 2,024 | 2,004 | 4,295 | 910 | 400 |
| Total Debt | 10,666 | N/A | 143 | 84 | 4,727 |
| Liquidity & working capital | |||||
| Current Ratio | 1.99x | 2.68x | 3.58x | 27.77x | 0.70x |
| Quick Ratio | 0.82x | 1.98x | 3.58x | 27.77x | 0.70x |
| Cash Ratio | 0.48x | 1.00x | 1.67x | 3.20x | 0.06x |
| Total Current Assets | 8,372 | 5,402 | 9,216 | 7,896 | 4,730 |
| Total Current Liabilities | 4,209 | 2,013 | 2,572 | 284 | 6,722 |
| Inventory | 4,938 | 1,414 | N/A | N/A | N/A |
| Trade Receivables | 1,395 | 1,936 | 522 | 2,345 | 187 |
| Trade Payables | 628 | 2,013 | 2,195 | 144 | 2,046 |
| Net Working Capital | 4,163 | 3,389 | 6,643 | 7,612 | -1,992 |
| Net Working Capital % of Revenue | 19.9% | 17.2% | 62.8% | 73.7% | -22.7% |
| Trade Working Capital | 5,705 | 1,337 | -1,673 | 2,201 | -1,860 |
| Trade Working Capital % of Revenue | 27.3% | 6.8% | -15.8% | 21.3% | -21.2% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | 2.35x | 7.08x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 155.4 | 51.5 | N/A | N/A | N/A |
| Receivables Turnover | 14.99x | 10.19x | 20.26x | 4.41x | 46.98x |
| Days Sales Outstanding (DSO) | 24.3 | 35.8 | 18.0 | 82.8 | 7.8 |
| Payables Turnover | 18.47x | 4.98x | 2.14x | 61.42x | 1.99x |
| Days Payable Outstanding (DPO) | 19.8 | 73.3 | 170.4 | 5.9 | 183.7 |
| Cash Conversion Cycle | 160.0 days | 14.0 days | -152.4 days | 76.9 days | -175.9 days |
| Asset Turnover | 1.58x | 2.70x | 0.98x | 1.28x | 1.51x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 532 | 1,174 | N/A | -220 | -722 |
| Free Cash Flow (OCF − Capex proxy) | 420 | 1,169 | N/A | 673 | -722 |
| Cash Conversion (OCF / EBITDA) | 18.0% | 364.0% | N/A | -29.2% | N/A |
| Dividends Declared | 0 | 511 | N/A | N/A | N/A |
| Dividend Payout Ratio | 0.0% | 167.1% | N/A | N/A | N/A |